New study: eradication of major antibiotic-resistant bacterial strains with chlorine dioxide
Dr. George Georgiou, Da Vinci Natural Health Center, Cyprus
Agnieszka Kotze – researcher
Problem: Antibiotic resistance
Bacterial antimicrobial resistance (AMR) is a problem in all regions, with six pathogens responsible for 73.4% of deaths attributable to bacterial AMR, namely:
– Escherichia coli (E. coli)
– Staphylococcus aureus (S. aureus)
– Klebsiella pneumoniae (K. pneumoniae)
– Streptococcus pneumoniae (S. pneumoniae)
– Acinetobacter baumannii (A baumannii) and
– Psuedomonas aeruginosa (P. aeruginosa).
Measures to date
The World Health Organization launched a Global Action Plan on AMR in 2021, which is still active – the healthcare costs of AMR are many billions of dollars worldwide. A UK government-commissioned study on antimicrobial resistance argued that antimicrobial resistance could kill 10 million people a year by 2050 and has emerged as one of the greatest public health threats of the 21st century. Only one AMR pathogen, methicillin-resistant Staphylococcus aureus (MRSA), caused more than 100,000 deaths worldwide, while the other four pathogens in this study caused as many deaths again.
This study uses chlorine dioxide
This research focused on investigating the efficacy of chlorine dioxide in eradicating five different AMR bacteria in vitro as a novel and effective treatment. In this study, different concentrations of chlorine dioxide were used with five antibiotic-resistant bacteria in the concentration range of 1 to 7 ppm.
Disinfection studies were compared to controls and results showed greater than 95% disinfection at concentrations of 7 ppm. Chlorine dioxide is a size-selective antimicrobial agent that can quickly kill micrometer-sized organisms, but does not cause actual harm to much larger organisms such as animals or humans because it cannot penetrate deeply into their living tissues. It is safe when used in low concentrations for short periods of time.
Clinical trials need to be conducted to gain experience with the best dosages and protocols for eliminating antibiotic-resistant microorganisms from the body.
this is the third chlorine dioxide study by Dr. George Georgiou of the Da Vinci Natural Health Center in Cyprus. All studies show how broadband and thoroughly chlorine dioxide works even at the lowest concentrations.
It is particularly important to note these days that this study was also conducted without outside funding and without conflicts of interest.
The company AQUARIUS pro life Ltd only provided laboratory samples of chlorine dioxide products in particular CDSplus® and the CDSpure® ampoules free of charge.